Rhoen-Klinikum does not expect takeover bid; to invest in Medtec start-ups - Boersen-ZeitungRhoen-Klinikum, a German hospital group, does not expect to receive a takeover bid anytime soon, Boersen-Zeitung reported. The German language newspaper quoted Jens-Peter Neumann, the chief financial officer of Rhoen-Klinikum. The article pointed out that the Rhoen-Klinikum share price currently stands at a record high of approximately EUR 28, meaning that the group is valued at approximately EUR 1.9bn.The report repeated that Asklepios, a German hospital group that already owns a significant stake in Rhoen-Klinikum, has been named as a potential bidder in the past. However, two sources close to the situation told the newspaper that Rhoen-Klinikum is currently too expensive for Asklepios. The latter could only finance a bid when the Rhoen-Klinikum share price drops below EUR 22.On a different note, Neumann revealed in the article that Rhoen-Klinikum intends to invest a low two-digit million Euro sum in Medtec start-ups this year. The aim is to improve the networking infrastructure of hospitals and gain access to new medical technologies. Neumann said that Rhoen-Klinikum is close to investing in a new cardio device. He explained that Rhoen-Klinikum is willing to acquire up to 30% in start-ups.Boersen-Zeitung